Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05498389 |
| Title | EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Shanghai EpimAb Biotherapeutics Co., Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine | Orange | California | 92868 | United States | Details | |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Guangdong Provincial People's Hospital | Guangzhou | Guangdong | 510080 | China | Details |